A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

NCT05171348 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CM326
DRUG: Placebo

Sponsor

Keymed Biosciences Co.Ltd